Login / Signup

Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.

Ottavia BernocchiMarianna SiricoSilvia Paola CoronaCarla StrinaManuela MilaniMaria Rosa CappellettiGiuseppina FerreroNicoletta ZiglioliValeria CervoniAndrea MacchiavelliGiandomenico RovielloDaniele Generali
Published in: Pharmaceuticals (Basel, Switzerland) (2021)
Our results confirm the emerging importance of molecular tumor profiling for the successful management of cancer, and the potential of BRAF-targeted therapy in the treatment of rare solid tumors with poor prognosis and no clinical benefit from systemic therapies with.
Keyphrases